Organon & Co | OGN - Ebit

Stock Price
8.10
Daily Change
-0.11 -1.28%
Monthly
8.80%
Yearly
-45.94%
Q1 Forecast
8.28

Organon & Co reported $388M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Bristol-Myers Squibb USD 4.04B 1.78B Sep/2025
Celltrion KRW 301.04B 58.57B Sep/2025
Cspc Pharmaceutical CNY 1.22B 60.54M Sep/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Divis Laboratories Ltd INR 7.75B 1.58B Sep/2025
Gilead Sciences USD 3.51B 810M Sep/2025
Glaxosmithkline GBP 3.76B 1.69B Sep/2025
Kangmei Pharma CNY -26.7M 43.13M Sep/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Malin Corporation EUR -1.1M 300K Dec/2024
Medical Developments International AUD -12.12M 3.97M Jun/2023
Merck USD 7.56B 1.19B Sep/2025
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024
Novartis USD 4.48B 343M Sep/2025
Organigram Holdings CAD -28.05M 25.94M Sep/2025
Organon & Co USD 388M 28M Sep/2025
Pharma Mar EUR -3.96M 28.11M Sep/2025
Qiagen NV USD 141.06M 6.64M Sep/2025
Sartorius EUR 150.1M 11.7M Sep/2025
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Tilray USD -20.01M 9.34M Sep/2025